In the relentless battle to beat malaria, Kenya must revolutionize its approach by reducing dependence on imported supplies and prioritizing the integration of manufacturing into its frontline defence against the disease.
For a disease that claims 29 lives daily, Kenya must proactively address challenges associated with external reliance, such as supply chain disruptions, cost fluctuations, and the inherent risk of strategic vulnerability. The fluctuating dollar, for instance, further worsens the already elevated costs of malaria treatment, particularly in developing nations like Kenya that heavily rely on
imports.
Every additional cent paid to access a dollar translates to more money spent on importing malaria commodities, exacerbating the financial burden.
Borrowing a neighbour’s tool for weed control might work once, but not for a constant battle. Just like the COVID-19 pandemic exposed the risks of overreliance on external supply chains, so too does Kenya’s malaria fight. The country needs a self-reliant
healthcare strategy, starting with the domestic production of medicines and malaria commodities.
32 million Kenyans live in malaria hotspots, a constant demand for life-saving bed nets, rapid tests, and antimalarial drugs. Every year, the government imports 20 million bed nets and replenishes millions more, relying heavily on external sources.
Considering the potential economic and human benefits, imagine the transformative impact that would unfold if Kenya were to produce these vital tools locally.
Local production means a steady supply of life-saving tools in the fight against malaria, even during global disruptions.
This reduced reliance on imported bed nets alone could free up government expenditures, empowering the country to invest in critical areas like healthcare infrastructure and community education. Every locally produced net or drug represents a protected family, a saved life, and a job created.
End Malaria Council Kenya is rallying the private sector to forge a “Made in Kenya” healthcare future, a commitment to producing malaria commodities right here.
This isn’t just business; it’s a national movement to shield communities, empower individuals, and build a self-reliant health shield. Invest in a future where malaria is a relic and health is the nation’s true wealth.
Opinion piece:
By Chris Getonga, Chair of the End Malaria Council Kenya.